Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-17

FDA Approved: KALYDECO — Supplemental Application (Vertex Pharmaceuticals Incorporated)

View source ↗

Summary

FDA approved a supplemental application for KALYDECO (ivacaftor) submitted by Vertex Pharmaceuticals Incorporated. The action updates the product labeling/indic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Kalydeco (ivacaftor)

Snippet

SUPPL AP for KALYDECO (IVACAFTOR)